# Trial of Ketamine and Lithium Therapy in Bipolar Depression

> **NCT01768767** · PHASE2 · WITHDRAWN · sponsor: **Yale University**

## Conditions studied

- Bipolar Depression

## Interventions

- **DRUG:** Placebo
- **DRUG:** Ketamine
- **DRUG:** Ketamine/Lithium

## Key facts

- **NCT ID:** NCT01768767
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-01
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No funding
- **Last updated:** 2023-03-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01768767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01768767, "Trial of Ketamine and Lithium Therapy in Bipolar Depression". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01768767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*